Stocks and Investing
Stocks and Investing
Fri, May 13, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Maintained (BLND) at Hold with Decreased Target to $3.5 on, May 13th, 2022
Arvind Ramnani of Piper Sandler, Maintained "Blend Labs, Inc." (BLND) at Hold with Decreased Target from $5.5 to $3.5 on, May 13th, 2022.
Arvind has made no other calls on BLND in the last 4 months.
There are 6 other peers that have a rating on BLND. Out of the 6 peers that are also analyzing BLND, 4 agree with Arvind's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Bhavan Suri of "William Blair" Downgraded from Buy to Hold on, Monday, April 4th, 2022
- Joseph Vafi of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $5 on, Friday, April 1st, 2022
- Terry Tillman of "Truist Securities" Maintained at Hold with Decreased Target to $5.5 on, Friday, April 1st, 2022
- Ryan Tomasello of "Keefe, Bruyette & Woods" Initiated at Hold and Held Target at $12 on, Monday, February 14th, 2022
These are the ratings of the 2 analyists that currently disagree with Arvind
- Michael Ng of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $7 on, Tuesday, April 19th, 2022
- Josh Beck of "Keybanc" Maintained at Buy with Decreased Target to $6 on, Friday, April 1st, 2022
Contributing Sources